Insulin C

Insulin C: Short-acting insulin from Germany

Insulin C is a short-acting drug used to treat diabetes. This insulin is produced in Germany by Hoechst AG. It belongs to the pharmacological group of short-acting insulins.

The international name for Insulin C is Insulin-BD. There are also several synonyms for this drug, including Berlinsulin N Normal U-40, Berlinsulin N Normal pen, Biogulin Regular U-100, Biogulin Regular U-40, Biosulin N, Brinsulrapi MK, Brinsulrapi H, Insulin, Insulin "M", Insulin Actrapid, Insulin Actrapid MK, Insulin Actrapid MS, Insulin Iletin II Regular, and others.

Insulin C is presented in the form of an injection solution containing 40 IU/ml. It is used to control blood sugar levels in patients with diabetes. Short-acting insulin has a rapid onset of action and a short half-life, which allows for rapid regulation of glucose levels after meals.

Insulin C is an important component in the treatment of diabetes and is used in combination with other forms of insulin to achieve optimal glycemic control. The dosage and regimen of Insulin C should be prescribed by a doctor based on the individual needs of the patient.

The manufacturing country Germany is known for its high quality standards in the production of pharmaceuticals. The production of Insulin C by Hoechst AG involves compliance with strict regulations and standards to ensure the safety and effectiveness of the drug.

In conclusion, Insulin C is a short-acting insulin manufactured in Germany by Hoechst AG. It is an injection solution containing 40 IU/ml and is used to control blood sugar levels in patients with diabetes. This drug plays an important role in the treatment of diabetes and requires a doctor's prescription to determine the correct dosage and regimen.